Sadly, it’s a one year milestone:
The DEP-Cabazitaxel Phase 2 results were released to the ASX back on 18th Oct 2023. From my notes on this day SPL finished down about 7% on huge volume.
And still no deal has been signed 12 months later.
P.S. On 28th January 2020, the captain of team brown posted on this forum that DEP-Cabazitaxel and DEP-Docetaxel would both be licenced out in 2020.
Lol. One is still not licenced 4 years later and the other has been shelved.
Sadly, it’s a one year milestone:The DEP-Cabazitaxel Phase 2...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.27M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4200 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 108148 | 2 |
View Market Depth
| Last trade - 16.21pm 11/09/2025 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable